"I founded Neurotrack to make cognitive testing as routine as checking blood pressure or cholesterol, and I hope other ...

A condition causing 'clogged drains' in the brain may be an early red flag of dementia, new research shows. Scientists now ...

Early-onset dementia is linked to shorter survival, with the highest mortality risk in patients with frontotemporal dementia, ...

Alzheimer's research has come a long way in recent years. New blood tests can diagnose the disease before symptoms present.

Choose a calm moment, listen first and give the person time to share how they feel. Here are some other tips on how to help a ...

A recent study published in JAMA Network Open highlights that emerging data support hearing loss as a key early-warning sign ...

Based on the efficacy results, Novo Nordisk has made the decision to discontinue the 1-year extension periods for these trials.

Despite encouraging biomarker shifts, oral semaglutide failed to slow cognitive decline in early Alzheimer’s, leading to an early end of the trial extension.

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

Two large-scale phase 3 trials found that semaglutide did not significantly slow cognitive decline in early-stage Alzheimer’s ...

Johnson & Johnson will discontinue the Phase II Auτonomy study of posdinemab after a scheduled review found the anti-tau ...